- Home
- PRQR vs BMN Comparison
PRQR vs BMN Comparison
Compare PRQR & BMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PRQR | BMN |
|---|---|---|
| Founded | 2012 | N/A |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 166.5M | 168.2M |
| IPO Year | 2014 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PRQR | BMN |
|---|---|---|
| Price | $1.53 | $25.55 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.25 | N/A |
| AVG Volume (30 Days) | ★ 710.7K | 11.9K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.92 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.33 | $23.90 |
| 52 Week High | $3.10 | $27.96 |
Technical Indicators
Market Signals| Indicator | PRQR | BMN |
|---|---|---|
| Relative Strength Index (RSI) | 42.73 | 45.22 |
| Support Level | $1.51 | $24.42 |
| Resistance Level | $1.58 | $26.28 |
| Average True Range (ATR) | 0.12 | 0.49 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 31.67 | 66.67 |
Price Performance
Historical ComparisonAbout PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.
About BMN BlackRock 2037 Municipal Target Term Trust of Beneficial Interest
BlackRock 2037 Mun Tgt is a non-diversified, closed-end management investment company. The Trust's investment objective is to provide current income that is exempt from regular federal income tax. The Trust invests in investment grade quality securities or securities that are unrated but judged to be of comparable quality by the investment adviser.